REQUEST A DEMO
Total
USD $0.00
Search more companies

Olikla S.R.O. (Czech Republic)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Hunting and Trapping | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Other Miscellaneous Store Retailers | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Advertising Agencies
Full name: Olikla S.R.O. Profile Updated: February 23, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Olikla S.R.O. is a Czech generic pharmaceutical company under the CZ Pharma platform, focused on the manufacture and sale of medicines marketed under the Olikla brand with an emphasis on hospital care. The company supplies a portfolio of pharmaceutical products for inpatient and specialized clinical use and complements its own branded medicines with additional products supplied to markets under exclusive distribution representation arrangements. It positions its business around reliable supply, regulated quality and portfolio development for healthcare providers and institutional customers.

Headquarters
namesti Smirickych 42
Kostelec nad Cernymi lesy; Stredocesky; Postal Code: 28163

Contact Details: Purchase the Olikla S.R.O. report to view the information.

Website: https://www.olikla.cz/

Basic Information
Total Employees:
Purchase the Olikla S.R.O. report to view the information.
Registered Capital:
Purchase the Olikla S.R.O. report to view the information.
Financial Auditors:
Purchase the Olikla S.R.O. report to view the information.
Incorporation Date:
October 31, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
90%
Company Performance
Financial values in the chart are available after Olikla S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
10.02%
Total operating revenue
9.83%
Operating Profit/Loss (EBIT)
17.62%
EBITDA
17.31%
Net Profit/Loss for the Period
21.54%
Total Assets
27.69%
Total Equity
26.86%
Operating Profit Margin (ROS)
0.46%
Net Profit Margin
0.44%
Return on Equity (ROE)
-0.93%
Debt/Equity
-64.6%
Quick Ratio
-0.18%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?